Gonadotropin Stimulation Reduces the Implantation and Live Birth Rate but Not the Miscarriage Rate of Embryos Transferred When Compared to Unstimulated In Vitro Fertilization
Open Access
- 29 June 2022
- journal article
- research article
- Published by Springer Nature in Reproductive Sciences
- Vol. 30 (1) , 283-290
Abstract
Research suggests that gonadotropin stimulation in in vitro fertilization (IVF) treatment affects embryo quality and the endometrium that might influence embryo implantation, placentation and establishment of a viable pregnancy. We assessed the impact of gonadotropin stimulation on implantation, live birth and miscarriage rates per transferred embryo by comparing stimulated and unstimulated IVF treatment. In a cohort of 728 couples, 1310 IVF cycles with successful embryo transfer were analysed; 857 cycles were stimulated with gonadotropins > 75 IU/day (333 poor responder < 4 oocytes; 524 normal responders), and 453 were unstimulated. In total, 1913 fresh cleavage-stage embryos were transferred. Zygote but no embryo selection was performed, and supernumerous zygotes were vitrified. The implantation rate was defined as number of sonographically detected amniotic sacs; live birth rate as number of children born per transferred embryo. Modified mixed effect Poisson regression was used to account for the dependency of cycles and embryos within the same women and the same transfer cycle. Adjustments were made for maternal age, parity, primary or secondary infertility and indication for IVF. Per transferred embryo, implantation rates (rate ratio (RR) 1.37; 95% CI 1.04–1.81; p = 0.028; aRR 1.42; 95% CI 1.10–1.84; p = 0.008) and live birth rates (RR 1.33; 95% CI 0.95–1.86; p = 0.093; aRR 1.38; 95% CI 1.01–1.88; p = 0.044) were higher in NC-IVF compared to cIVF normal responders. Miscarriage did not differ (RR 0.99; 95% CI 0.59–1.65; p = 0.965; aRR 0.90; 95% CI 0.52–1.53 p = 0.698). Similar results were obtained in poor responders. The study suggests an impact of gonadotropin stimulation on the implantation potential of embryos.Keywords
Funding Information
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (P2BEP3-191798)
- Institut Biochimique SA
- Merck Switzerland
- Norges Forskningsråd (262700)
- University of Bern
This publication has 42 references indexed in Scilit:
- Prematurely Elevating Estradiol in Early Baboon Pregnancy Suppresses Uterine Artery Remodeling and Expression of Extravillous Placental Vascular Endothelial Growth Factor and α1β1 and α5β1 IntegrinsEndocrinology, 2012
- Association between the number of eggs and live birth in IVF treatment: an analysis of 400 135 treatment cyclesHuman Reproduction, 2011
- What does it take to make a developmentally competent mammalian egg?Human Reproduction Update, 2011
- Predictive factors in in vitro fertilization (IVF): a systematic review and meta-analysisHuman Reproduction Update, 2010
- Mouse Oocyte Control of Granulosa Cell Development and Function: Paracrine Regulation of Cumulus Cell MetabolismSeminars in Reproductive Medicine, 2009
- Suppression of Extravillous Trophoblast Vascular Endothelial Growth Factor Expression and Uterine Spiral Artery Invasion by Estrogen during Early Baboon PregnancyEndocrinology, 2008
- Oocyte-secreted factors: regulators of cumulus cell function and oocyte qualityHuman Reproduction Update, 2008
- Increased risk of placenta previa in pregnancies following IVF/ICSI; a comparison of ART and non-ART pregnancies in the same motherHuman Reproduction, 2006
- Measurement of dimeric inhibin B throughout the human menstrual cycle.The Journal of Clinical Endocrinology & Metabolism, 1996
- Measurement of dimeric inhibin B throughout the human menstrual cycleThe Journal of Clinical Endocrinology & Metabolism, 1996